Clinical trial of Amalaki Rasayan in post covid patients

Manufacturing, Analysis And Exploratory Clinical Trial Of Charakokta Amalaki Rasayan in POST COVID Patients

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042410

Enrollment

Registered

2022-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Post covid patients beyond 4 weeks of infection up to one year after active infection of covid 19, patients having symptoms of fatigue, anorexia, anxiety, headache, joint pain, dysponea

Exclusion criteria

Exclusion criteria: Patients with active covid 19 infection, any critical emergencies including cardiac diseases, known case of asthma, COPD, ARDS, critical post covid complications like stroke, renal failure, myocarditis, mukermycosis, etc, uncontrolled DM, HTN

Design outcomes

Primary

Measure	Time frame
Improvement in WHO well being index and improvement in symptoms after 30 days interventionTimepoint: Improvement in WHO well being index and improvement in symptoms after 30 days intervention	—

Secondary

Measure	Time frame
Improvement in WHO well being index and improvement in symptoms after 30 days interventionTimepoint: 30th day after intervention	—

Countries

India

Contacts

Public ContactDr Trupti Patil

BVDU College of Ayurved, Bharati Vidyapeeth (Deemed to be University), Pune 411043

truptibhole@gmail.com02024373954

Outcome results